Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06364748 · ClinicalTrials.gov registry record · NA
Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer
A NA study, sponsored by West Michigan Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06364748: Completed NA study, sponsored by West Michigan Cancer Center.
NCT06364748 is a NA study that has completed, run by West Michigan Cancer Center. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06364748, a NA study, has completed, sponsored by West Michigan Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
A randomized trial of remote blood pressure monitoring, compared to usual care, in patients receiving bevacizumab to determine whether remote blood pressure monitoring improves the collection of blood pressure data, identification and management of clinically significant hypertension, and patient satisfaction.
Primary Outcome
Comparing the number of participants who complete the recommended daily blood pressure readings available for clinician assessment via review of a remote blood pressure monitoring platform versus a patient recorded blood pressure log book
Interventions
- DEVICE Cellular enabled blood pressure cuff
- DEVICE Standard of Care Cuff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-03-11 |
| Est. Completion | 2025-09-26 |
| Phase | NA |
What the finished NCT06364748 record still lists
NCT06364748 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Cellular enabled blood pressure cuff is the first listed.
NCT06364748 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06364748 about?
NCT06364748 is a clinical study titled "Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer". A randomized trial of remote blood pressure monitoring, compared to usual care, in patients receiving bevacizumab to determine whether remote blood pressure monitoring improves the collection of blood pressure data, identification and management of clinically significant hypertension, and patient sa...
What is the current status of trial NCT06364748?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-03-11. Estimated completion is 2025-09-26.
What interventions are being tested in trial NCT06364748?
The interventions under investigation include: Cellular enabled blood pressure cuff (DEVICE), Standard of Care Cuff (DEVICE).
Who is sponsoring clinical trial NCT06364748?
This trial is sponsored by West Michigan Cancer Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06364748's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI